Ronald L. Meeusen is Director at ARATANA THERAPEUTICS, INC. (PETX). They have made 1 open-market trade across 1 company since 2014, most recently 2014-02-03.
CIK 0001578907
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PETX | 75,332 | $371K |
Shares reported on the most recent Form 4, priced at the 2014-02-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PETX | SELL | 2014-02-03 | 2014-02-05 | $19.00 | $9.5M | -45.1% | -7.4% | -7.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.